Margaret Tempero

Credentials: · · · · · ·

History

NCCN Guidelines Panel on Pancreatic Cancer Department · National Comprehensive Cancer Network
2000–Present
UCSF Pancreas Center · University of California, San Francisco
Present
Division of Medical Oncology · University of California, San Francisco
Present

Perioperative Stromal Depletion Strategies in Pancreatic Ductal Adenocarcinoma
National Cancer Institute · R21
Contact PI · $365.8K · University of California, San Francisco
2014–2018
Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $4M · University of California, San Francisco
2007–2012
Mechanism-Based Evaluations of ErbB-Targeted Agents
National Cancer Institute · U54
Contact PI · $5.6M · University of California, San Francisco
2001–2008
Spore in Gastointestinal Cancer
National Cancer Institute · P50
Contact PI · $3.3M · University of Nebraska Medical Center
1997–2005

Ibrutinib Combined With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer
Principal investigator · Completed · Phase 1, Phase 2
Margaret Tempero
2015–2020
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer
Study chair · Withdrawn · Phase 1
University of California, San Francisco
2001
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Study chair · Completed · Phase 2
Alliance for Clinical Trials in Oncology
1998–2006
Pancreatic Cancer Early Detection Consortium
Site PI · Recruiting
Arbor Research Collaborative for Health
2020–2030